Literature DB >> 9174198

Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.

J D Vrany1, P S Stewart, P A Suci.   

Abstract

Attenuated total reflection Fourier transform infrared spectroscopy was used to measure transport of the fluoroquinolones (FQs) ciprofloxacin and levofloxacin into Pseudomonas aeruginosa biofilms. Biofilms were exposed to each FQ at dose levels of 100, 250, and 500 microg/ml for 30 min. A mathematical transport model was used to extract the diffusion coefficient, binding site density, and adsorption and desorption rates for each experiment. Recalcitrance of the biofilms toward each FQ was evaluated by comparison of efficacies with planktonic bacteria. By this criterion, biofilms were found to exhibit more recalcitrance toward levofloxacin than ciprofloxacin under the experimental conditions. These results cannot be explained by the more hindered transport of levofloxacin, implicating the domination of physiological factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174198      PMCID: PMC163914          DOI: 10.1128/AAC.41.6.1352

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

Review 1.  Structure-activity relationships of the fluoroquinolones.

Authors:  D T Chu; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate.

Authors:  N A Hodges; C A Gordon
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 3.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response.

Authors:  P Gilbert; P J Collier; M R Brown
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

4.  Inactivation of biofilm bacteria.

Authors:  M W LeChevallier; C D Cawthon; R G Lee
Journal:  Appl Environ Microbiol       Date:  1988-10       Impact factor: 4.792

5.  In vivo verification of in vitro model of antibiotic treatment of device-related infection.

Authors:  J Blaser; P Vergères; A F Widmer; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

6.  Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms.

Authors:  P A Suci; M W Mittelman; F P Yu; G G Geesey
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase.

Authors:  C J Willmott; S E Critchlow; I C Eperon; A Maxwell
Journal:  J Mol Biol       Date:  1994-09-30       Impact factor: 5.469

8.  Photosynthate partitioning and fermentation in hot spring microbial mat communities.

Authors:  S C Nold; D M Ward
Journal:  Appl Environ Microbiol       Date:  1996-12       Impact factor: 4.792

9.  Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin.

Authors:  B D Hoyle; J Alcantara; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.

Authors:  A Kitamura; K Hoshino; Y Kimura; I Hayakawa; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  31 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

3.  Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms.

Authors:  Philip S Stewart; Michael J Franklin; Kerry S Williamson; James P Folsom; Laura Boegli; Garth A James
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

Review 4.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

5.  Antimicrobial Tolerance in Biofilms.

Authors:  Philip S Stewart
Journal:  Microbiol Spectr       Date:  2015-06

6.  Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.

Authors:  Mia Mae Kiamco; Erhan Atci; Abdelrhman Mohamed; Douglas R Call; Haluk Beyenal
Journal:  Appl Environ Microbiol       Date:  2017-03-02       Impact factor: 4.792

Review 7.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

8.  Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.

Authors:  J N Anderl; M J Franklin; P S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

9.  Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.

Authors:  Philip S Stewart; Ben White; Laura Boegli; Timothy Hamerly; Kerry S Williamson; Michael J Franklin; Brian Bothner; Garth A James; Steve Fisher; Francisco G Vital-Lopez; Anders Wallqvist
Journal:  J Bacteriol       Date:  2019-10-21       Impact factor: 3.490

Review 10.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.